BOSTON SCIENTIFIC MISSES FORECASTS AFTER CYBER ATTACK

Boston Scientific Corp. disclosed that a recent cyber attack has significantly impacted operations, preventing the company from meeting previously issued financial forecasts. The medical devices manufacturer, which produces equipment used in cardiac care, urology, and other healthcare sectors, confirmed that the cybersecurity incident has created bottlenecks in its ability to distribute products to hospitals and healthcare facilities. The company announced it would revise down its full-year sales growth estimates and earnings per share projections. The specific financial impact remains under assessment as the company works to restore normal operations. Boston Scientific did not disclose details about the nature of the cyber attack, its scope, or the timeline for full recovery. The company also did not provide updated financial targets. The incident underscores growing vulnerabilities in the healthcare sector, where medical device makers face increasing pressure from sophisticated cyber threats. Supply chain disruptions at major medical device manufacturers can have cascading effects across the healthcare system, potentially delaying patient treatments. Boston Scientific joins other major corporations that have experienced operational disruptions from cyber attacks in recent years. The company manufactures pacemakers, stents, orthopedic devices, and other medical equipment relied upon by healthcare providers globally. The company said it is working with external cybersecurity experts and law enforcement to investigate the incident and implement remediation measures. Restoring full manufacturing and distribution capacity is a priority as the company works to minimize impact to patients and healthcare providers. Boston Scientific's disclosure serves as a reminder of the interconnected nature of modern supply chains and the real-world consequences when critical infrastructure is compromised.